Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis.

Endocrine-related cancer - 1 Jun 2018

Vuong Huy Gia, Odate Toru, Ngo Hanh T T, Pham Thong Quang, Tran Thao T K, Mochizuki Kunio, Nakazawa Tadao, Katoh Ryohei, Kondo Tetsuo

Abstract excerpt

There are ongoing debates with respect to the prognostic roles of molecular biomarkers in sporadic medullary thyroid carcinoma (MTC). In this study, we aimed at investigating the prognostic value of RET and RAS mutations - the two most common mutations in sporadic MTCs. A search was conducted in four electronic databases. Relevant data were extracted and pooled into odds ratios (OR), mean differences (MD) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Neuroendocrine
Share to RET gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphatic Metastasis

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Proto-Oncogene Proteins c-ret

Share to Proto-Oncogene Proteins p21(ras)

Share to Thyroid Neoplasms

Source

Identifiers

PMID: 29615431
DOI: 10.1530/ERC-18-0056

Genes

RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis.PMID 29615431Read ↗

Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.Semantic proximity Read ↗

Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted SequencingSemantic proximity Read ↗

A cohort study on 10-year survival of sporadic medullary thyroid carcinoma with somatic RET mutation.Semantic proximity Read ↗

Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up StudySemantic proximity Read ↗

Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RETSemantic proximity Read ↗

Sporadic and familial medullary thyroid carcinoma: state of the art.Semantic proximity Read ↗

Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease AggressivenessSemantic proximity Read ↗

Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.Semantic proximity Read ↗

Medullary thyroid cancer: molecular factors, management and treatment.Semantic proximity Read ↗

Medullary thyroid carcinoma (MTC) and RET proto-oncogene: mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form.Semantic proximity Read ↗

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.Semantic proximity Read ↗

Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectivesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.